Introduction to the United States Ultrasound Device Market
The United States healthcare landscape continues to experience strong demand for advanced, non-invasive diagnostic tools. According to recent market analysis, the United States Ultrasound Device Market is expected to reach US$ 4.32 billion by 2034, expanding from US$ 2.73 billion in 2025 at a compound annual growth rate (CAGR) of 5.23% from 2026 to 2034.
This robust growth is propelled by the rapid adoption of portable and point-of-care ultrasound (POCUS) systems, a rising prevalence of chronic conditions, and the integration of artificial intelligence (AI) to enhance clinical accuracy and workflow efficiency.
Download Free Sample Report: https://www.renub.com/request-sample-page.php?gturl=united-states-ultrasound-devices-market-p.php
Industry Overview and Market Dynamics
Ultrasound devices are medical imaging systems that utilize high-frequency sound waves to capture real-time visual representations of internal organs, tissues, and blood flow. Widely deployed across specialties such as cardiology, obstetrics, oncology, and emergency medicine, these systems range from traditional heavy cart-based units to compact, handheld probes connecting directly to tablets and smartphones.
Core Growth Drivers
-
Technological Innovation and AI Integration: Modern ultrasound systems increasingly feature AI-assisted tools to automate image interpretation, measure anatomical structures, and optimize settings. Handheld, wireless, and cloud-connected probes enable immediate bedside diagnostics.
-
Increasing Chronic Diseases & Aging Population: Prevalence of cardiovascular disorders, diabetes complications, and cancers among a growing elderly demographic drives high imaging volumes and regular monitoring needs.
-
Expansion of Point-of-Care Ultrasound (POCUS): POCUS is transforming emergency medicine, critical care, and primary practice by bringing immediate diagnostic imaging directly to patients, reducing hospital admissions and expediting clinical decisions.
Major Market Challenges
-
Regulatory and Integration Limitations: AI-enhanced software requires rigorous validation and lengthy FDA reviews. Interoperability issues with electronic health records (EHR) and cybersecurity compliance also present operational hurdles.
-
Competition From Advanced Imaging Modalities: High-precision diagnostic needs in neurology and oncology often favor high-resolution modalities like MRI, CT, and PET scanners.
Regional Market Highlights
California
Strengthened by an advanced healthcare infrastructure and high patient volume, California leads in adopting AI-driven imaging tools and handheld devices across major medical hubs in Los Angeles, San Francisco, and San Diego.
Texas
Driven by a large population and rapidly expanding healthcare networks in Houston, Dallas, and Austin, Texas relies heavily on ultrasound to manage high rates of chronic illnesses and support rural trauma care.
New York
Anchored by world-class medical institutions and high patient throughput, New York demonstrates strong demand for 3D/4D imaging and AI-guided diagnostics in cardiology and oncology.
Florida
Propelled by a large retiree demographic and extensive outpatient facilities, Florida extensively utilizes ultrasound for cardiovascular screenings, women’s health, and chronic disease management.
Recent Market Developments
-
GE HealthCare (January 2025): Received U.S. FDA 510(k) clearance for its upgraded Voluson Expert Series (Voluson Expert 22, 20, and 18 models).
-
GE HealthCare (March 2025): Launched the Automated Breast Ultrasound Premium platform integrating advanced AI for enhanced supplemental breast screening in dense tissue.
-
Vave Health (March 2025): Introduced a wireless, handheld ultrasound device powered by a single PZT transducer for versatile whole-body imaging.
-
MedShare, BD, and National Association of Free and Charitable Clinics (March 2025): Supplied 92 new portable ultrasound units to safety-net clinics across 30 U.S. states to expand diagnostic access in underserved regions.
Market Segmentation
-
Products: Diagnostics Ultrasound, Therapeutic Ultrasound
-
Portability: Trolley/Cart-based Ultrasound Devices, Compact/Handheld Ultrasound Devices
-
Application: Radiology/General Imaging, Cardiology, Gynecology, Vascular, Urology, Others
-
End-Users: Hospitals, Surgical Centers, Diagnostic Centers, Maternity Centers, Ambulatory Care Centers, Academic Institutions
-
Top States Covered: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Georgia, New Jersey, Washington, North Carolina, Massachusetts, Virginia, Michigan, Maryland, Colorado, Tennessee, Indiana, Arizona, Minnesota, Wisconsin, Missouri, Connecticut, South Carolina, Oregon, Louisiana, Alabama, Kentucky, and Rest of United States.
Competitive Landscape
The U.S. ultrasound device market features intense competition among leading medical imaging innovators. Companies are evaluated across Overviews, Key Persons, Recent Developments, SWOT Analyses, and Revenue Performance:
-
GE Healthcare
-
Hologic Inc.
-
Butterfly Network
-
Hitachi Healthcare Americas
-
Samsung Electronics Co. Ltd.
-
Fujifilm Holdings Corporation
